Version 2.78

Descriptions

Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (Europe) and Tyzeka (United States). Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause resistance. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Telbivudine

Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia

Basic Part Properties

Part Display Name
Telbivudine
Part Type
Component (Describes the core component or analyte measured)
Created On
2009-08-14
Construct for LOINC Short Name
Telbivudine

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP96214-9
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP96214-9

Language Variants Get Info

Tag Language Translation
et-EE Estonian (Estonia) Telbivudiin
es-ES Spanish (Spain) Telbivudina
it-IT Italian (Italy) Telbivudina
tr-TR Turkish (Turkey) Telbivudin
ru-RU Russian (Russian Federation) Телбивудин
nl-NL Dutch (Netherlands) telbivudine
fr-BE French (Belgium) Telbivudine
zh-CN Chinese (China) 替比夫定